GSK's Chinese executives, but not company, likely to face charges in China: sources

By Adam Jourdan SHANGHAI (Reuters) - Chinese police investigating allegations of widespread corrupt practices at GlaxoSmithKline Plc (GSK) are likely to charge some of its Chinese executives but not the British drugmaker itself, legal and industry sources said. A charge against GSK itself would be a much more serious outcome for the company because it would imply higher-level corporate involvement and could result in major fines and even disruption to its operations in China. Police are also unlikely to lay criminal charges against Briton Mark Reilly, GSK's former head of China operations, the sources said. Reilly has been voluntarily assisting authorities following Chinese police accusations in July that GSK funneled up to 3 billion yuan ($492 million) to travel agencies to facilitate bribes to doctors and officials to boost its drug sales.

via Health News Headlines - Yahoo! News http://news.yahoo.com/gsks-chinese-execs-not-company-likely-face-charges-090817362--finance.html